Citadel Advisors
DNA icon

Citadel Advisors’s Ginkgo Bioworks DNA Stock Holding History

Citadel Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
+130,935
New +$1.09M ﹤0.01% 7556
2025
Q3 		– Sell
-10,114
Closed -$121K – 13010
2025
Q2 		$114K Buy
+10,114
New +$78.4K ﹤0.01% 11233
2025
Q1 		– Sell
-141,735
Closed -$1.44M – 14669
2024
Q4 		$1.39M Buy
+141,735
New +$1.21M ﹤0.01% 6375
2024
Q2 		– Sell
-113,226
Closed -$3.38M – 14452
2024
Q1 		$5.25M Buy
113,226
+42,852
+61% +$2.22M ﹤0.01% 3883
2023
Q4 		$4.76M Sell
70,374
-60,707
-46% -$3.72M ﹤0.01% 3868
2023
Q3 		$9.49M Buy
131,081
+105,249
+407% +$8.41M ﹤0.01% 2753
2023
Q2 		$1.92M Buy
25,832
+2,872
+13% +$170K ﹤0.01% 5215
2023
Q1 		$1.22M Buy
22,960
+19,891
+648% +$1.26M ﹤0.01% 6349
2022
Q4 		$207K Sell
3,069
-375
-11% -$34.5K ﹤0.01% 10068
2022
Q3 		$430K Sell
3,444
-59,596
-95% -$7.1M ﹤0.01% 8796
2022
Q2 		$6M Buy
63,040
+62,170
+7,146% +$7.58M ﹤0.01% 3475
2022
Q1 		$141K Sell
870
-15,413
-95% -$3M ﹤0.01% 11924
2021
Q4 		$5.41M Sell
16,283
-9,775
-38% -$4.64M ﹤0.01% 4155
2021
Q3 		$12M Buy
+26,058
New +$12.7M ﹤0.01% 2754

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Citadel Advisors's DNA Position: Q2 2026 in Review

Citadel Advisors opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 130,935 shares worth $1.3M. The stake represents ﹤0.01% of the portfolio and ranks #7556 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in DNA as recently as Q2 2025.

Citadel Advisors first reported a position in DNA in Q3 2021 and has held it in 14 quarters since. The position peaked at $12M in Q3 2021. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Citadel Advisors held 130,935 shares of Ginkgo Bioworks worth $1.3M as of Q2 2026.
  • Ginkgo Bioworks was a new Citadel Advisors position in Q2 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7556 holding.
  • Citadel Advisors first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 14 quarters since.
  • Citadel Advisors's Ginkgo Bioworks position peaked at $12M in Q3 2021.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.